Claritas HealthTech has received U.S. Food and Drug Administration (FDA) 510(k) clearance for iRAD, an image processing program.
iRad was designed to reduce noise and improve contrast and entropy in MRI, CT, and x-ray images, the company said. The software can be integrated into existing PACS, where enhanced images can be compared with original images.
Image enhancement can be performed locally onsite or on the cloud. In addition, the product provides physicians with adjustable controls to calibrate the degree of enhancement of each parameter, Claritas said.
iRAD is currently in pilot clinical use, and Claritas will now look to form partnerships with leading medical and academic institutions to enter the U.S. market, the company said.
